The objective of this study is to demonstrate the effectiveness and feasibility in treating
empyema after pulmonary resection with a modified Clagett procedure performed at the bedside (
BMCP). A retrospective review of a single surgeon's experience at a single institution was undertaken. All operative, postoperative, and outcome data were analyzed. Follow-up data were obtained from subsequent clinic charts. Five patients, including four males, were identified who underwent
BMCP after pulmonary resection. The original operative procedures included two lobectomies, one
pneumonectomy, one bilobectomy, and one bilateral metastastectomy. Patients were diagnosed with an
empyema (positive
thoracostomy tube culture,
fever, and radiographic abnormality) at a mean time of 31 days from their initial procedure. Culture results disclosed Gram-positive empyemas in all patients. Three patients underwent
BMCP as an outpatient, whereas the other two had
BMCP during their hospitalizations. All patients are free from complications or recurrence at a mean follow up of 11.2 months. No patient required a further procedure after
BMCP. The bedside modified Clagett procedure is both safe and effective. It is a valuable option in the management of postoperative
empyema because it avoids additional operative procedures. This procedure is cost-effective when compared with operative management of perioperative
empyema.